|Articles|June 1, 2017
- Pharmaceutical Executive-06-01-2017
- Volume 37
- Issue 6
Pharmaceutical Executive, June 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive June 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Pharm Exec's Top 50 Companies 2017almost 9 years ago
Navigating Through Disruption: A Pharma 50 Viewalmost 9 years ago
Tips for Success from a Big Pharma Leaderalmost 9 years ago
The Quest for Meaningful Pharma-Patient Dialoguealmost 9 years ago
Executive Roundtable: Where is Your Physician?almost 9 years ago
Talent That Takes You into the Futurealmost 9 years ago
Europe: A Long Summer of Drug Pricing Tensionalmost 9 years ago
Gottlieb Takes Reins at FDA, Big Issues Loomalmost 9 years ago
Country Report: TaiwanAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
The Risks and Benefits of FDA Reviewing Real-Time Data
3
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
4
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
5